Similar articles for PMID: 31068410

Year	Number of Results
1991	1
2000	2
2002	1
2003	2
2004	1
2005	3
2006	3
2007	3
2008	2
2009	5
2010	4
2011	4
2012	4
2013	10
2014	14
2015	19
2016	15
2017	16
2018	7
2019	10
2020	7
2021	0

1

Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions.

Perreault L, Vincent L, Neumiller JJ, Santos-Cavaiola T. Perreault L, et al. J Am Board Fam Med. 2019 May-Jun;32(3):431-447. doi: 10.3122/jabfm.2019.03.180162. J Am Board Fam Med. 2019. PMID: 31068410 Free article. Review.

2

Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.

Berard L, Bonnemaire M, Mical M, Edelman S. Berard L, et al. Diabetes Obes Metab. 2018 Feb;20(2):301-308. doi: 10.1111/dom.13064. Epub 2017 Sep 12. Diabetes Obes Metab. 2018. PMID: 28719066 Free PMC article.

3

An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.

Blackberry ID, Furler JS, Ginnivan LE, Manski-Nankervis JA, Jenkins A, Cohen N, Best JD, Young D, Liew D, Ward G, O'Neal DN. Blackberry ID, et al. Diabetes Res Clin Pract. 2014 Nov;106(2):247-55. doi: 10.1016/j.diabres.2014.08.011. Epub 2014 Sep 8. Diabetes Res Clin Pract. 2014. PMID: 25271117 Clinical Trial.

4

Overcoming barriers to insulin replacement.

Kuritzky L. Kuritzky L. J Fam Pract. 2009 Aug;58(8 Suppl):S25-31. J Fam Pract. 2009. PMID: 19679028 Review. No abstract available.

5

[Insulin therapy in type 2 diabetes].

Hummel M. Hummel M. MMW Fortschr Med. 2011 Jun 9;153(23):56-9, 61; quiz 62. doi: 10.1007/BF03368528. MMW Fortschr Med. 2011. PMID: 21688497 German. No abstract available.

6

Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".

Ghosal S, Sinha B, Majumder A, Das AK, Singh AK, Ghoshdastidar B, Maji D, Goyal G, Mukherjee JJ, Gangopadhyay KK, John M, Chatterjee S, Jaggi S, Ray S, Majumdar S, Sharma SK. Ghosal S, et al. J Assoc Physicians India. 2017 Jul;65(7):51-62. J Assoc Physicians India. 2017. PMID: 28792170

7

Benefits of timely basal insulin control in patients with type 2 diabetes.

Lovre D, Fonseca V. Lovre D, et al. J Diabetes Complications. 2015 Mar;29(2):295-301. doi: 10.1016/j.jdiacomp.2014.11.018. Epub 2014 Dec 5. J Diabetes Complications. 2015. PMID: 25536866 Free article. Review.

8

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Vanderheiden A, Harrison L, Warshauer J, Li X, Adams-Huet B, Lingvay I. Vanderheiden A, et al. JAMA Intern Med. 2016 Jul 1;176(7):939-47. doi: 10.1001/jamainternmed.2016.1540. JAMA Intern Med. 2016. PMID: 27273731 Clinical Trial.

9

Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus.

Sheu WH, Park SW, Gong Y, Pinnetti S, Bhattacharya S, Patel S, Seck T, Woerle HJ. Sheu WH, et al. Curr Med Res Opin. 2015 Mar;31(3):503-12. doi: 10.1185/03007995.2015.1010638. Epub 2015 Feb 13. Curr Med Res Opin. 2015. PMID: 25629790 Clinical Trial.

10

Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control.

Philis-Tsimikas A. Philis-Tsimikas A. Am J Med. 2013 Sep;126(9 Suppl 1):S21-7. doi: 10.1016/j.amjmed.2013.06.010. Am J Med. 2013. PMID: 23953076 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed